First immunotherapy-based treatment recommended for advanced anal cancer

View source ↗

Summary

The European Medicines Agency recommended approval of Zynyz as the first immunotherapy-based treatment option for adults with anal canal squamous cell carcinoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Canal Squamous Cell Carcinoma

Drugs mentioned

• ZYNYZ (RETIFANLIMAB-DLWR)

Snippet

Zynyz provides an option for adults with squamous cell carcinoma of the anal canal